Literature DB >> 22466491

Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.

Carol L Shields1, Swathi Kaliki, Minoru Furuta, Arman Mashayekhi, Jerry A Shields.   

Abstract

PURPOSE: To evaluate clinical features and life prognosis of uveal melanoma based on age at presentation.
DESIGN: Retrospective, nonrandomized, interventional case series.
RESULTS: Of 8,033 eyes with uveal melanoma, 106 (1%) were in young patients (≤20 years), 4,287 (53%) in mid adults (21-60 years), and 3,640 (45%) in older adults (>60 years). Based on age (young, mid adults, and older adults) at presentation, tumor epicenter was located in iris (21, 4, 2%; P < 0.0001), ciliary body (8, 5, and 7%; P = 0.0225), or choroid (71, 91, and 90%; P < 0.0001). Mean tumor diameter (10.2, 10.8, 11.5 mm; P < 0.0001), mean tumor thickness (5.0, 5.3, 5.7 mm; P < 0.0001), and extraocular extension (1, 2, and 4%; P = 0.0004) increased with age. Kaplan-Meier estimates of tumor-related metastasis at 3, 5, 10, and 20 years were 2%, 9%, 9%, and 20% in young patients (P < 0.011); 6%, 12%, 23%, and 34% in mid adults (P < 0.0001); and 11%, 19%, 28%, and 39% in older adults. Kaplan-Meier estimate of tumor-related death at 3, 5, 10, and 20 years were 0%, 2%, 5%, and 17% in young patients (P = 0.08); 3%, 6%, 11%, and 17% in mid adults (P < 0.001); and 7%, 11%, 16%, and 20% in older adults.
CONCLUSION: Compared with mid adults and older adults, young patients manifested a higher proportion of iris melanoma. Compared with older adults, young and mid adults showed smaller melanoma basal dimension and lower tumor-related metastasis and death.

Entities:  

Mesh:

Year:  2012        PMID: 22466491     DOI: 10.1097/IAE.0b013e31824d09a8

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  75 in total

1.  Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?

Authors:  M K Singh; N Pushker; R Meel; K Chodsol; S Sen; S Bakhshi; L Singh; S Kashyap
Journal:  Clin Transl Oncol       Date:  2018-05-23       Impact factor: 3.405

2.  Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.

Authors:  Matthew V Fry; James J Augsburger; Zélia M Corrêa
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

3.  Uveal melanoma-associated survival in Scotland.

Authors:  Aaron Jamison; Lesley A Bhatti; Manvi M Sobti; Vikas Chadha; Paul Cauchi; Ewan G Kemp
Journal:  Eye (Lond)       Date:  2019-10-25       Impact factor: 3.775

4.  Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child.

Authors:  Helen Dimaras; Manoj Vijay Parulekar; Grace Kwok; E Rand Simpson; Asim Ali; William Halliday; Mary Shago; J William Harbour; Elise Héon; Brenda L Gallie; Helen S L Chan
Journal:  Br J Ophthalmol       Date:  2013-01-03       Impact factor: 4.638

Review 5.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

6.  Orbital recurrence of iris melanoma 21 years after enucleation.

Authors:  Emilie Bergeron; Nadia Lihimdi; Dan Bergeron; Solange Landreville
Journal:  BMJ Case Rep       Date:  2017-09-07

Review 7.  Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture.

Authors:  C L Shields; S Kaliki; M N Cohen; P W Shields; M Furuta; J A Shields
Journal:  Eye (Lond)       Date:  2015-08-07       Impact factor: 3.775

8.  Uveal Melanoma with Massive Extraocular Extension through the Sclerocorneal Limbus.

Authors:  Hyerin Jeong; Ho-Seok Sa
Journal:  Korean J Ophthalmol       Date:  2015-08

Review 9.  [Uveal and iridociliary melanomas in young patients : A retrospective analysis of 57 cases].

Authors:  L J Heyer; C Metz; D Flühs; C M Heyer; N Bornfeld
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

10.  Uveal melanoma in children and teenagers.

Authors:  Carol L Shields; Swathi Kaliki; Sruthi Arepalli; Hatice Tuba Atalay; Fairooz P Manjandavida; Guilia Pieretti; Jerry A Shields
Journal:  Saudi J Ophthalmol       Date:  2013-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.